|
|
Received: 20 December 2013
|
|
|
|
|
[6] |
Wirkowski E,Libman R B,Batash M.Hashimoto’S encephalopathy response to intravenous immunoglobulin[J].Stroke Cerebrovasc Dis,2007,7(6):265.
|
[1] |
Ferraci F,Bertiato G,Moretto G.Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations[J].J Neurol Sci,2004,217(2):165-168.
|
[7] |
姜 明,沈 扬,樊东升.桥本脑病研究进展[J].中华神经医学杂志,2008,7(5):536-537.
|
[2] |
Ferlazzo E,Rafaele M,Mazzu I,et al.Recurrent status epilepticus as the main feature of Hashimoto’s encephalopathy[J].Epilepsy Behav,2006,8(1):328-330.
|
[8] |
刘 丽,张朝东.桥本脑病的病因、临床表现和治疗[J].中华神经科杂志,2008,41(9):640-642.
|
[3] |
Duffey P,Yee S,Reid I N, et al. Hashimoto’s encephalopathy: postmortem findings after fatal status epilepticus[J].Neurology,2003,61(8):1124-1126.
|
[4] |
Kothbauer-Marhreiter I, Sturzwneger M, Komor J, et al.Encephalopathy associated with Hashimoto thyroiditis:diagnosis and treatment[J].J Neurol,1996,243(8):585-593.
|
[5] |
Watemberg N,Greenstein D,Levine A.Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective[J].J Child Neurol,2006,21 (1):1-5.
|
[6] |
Wirkowski E,Libman R B,Batash M.Hashimoto’S encephalopathy response to intravenous immunoglobulin[J].Stroke Cerebrovasc Dis,2007,7(6):265.
|
[7] |
姜 明,沈 扬,樊东升.桥本脑病研究进展[J].中华神经医学杂志,2008,7(5):536-537.
|
[8] |
刘 丽,张朝东.桥本脑病的病因、临床表现和治疗[J].中华神经科杂志,2008,41(9):640-642.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(3): 249-250. |
|
|
|